Company & Sponsor Intelligence

Medical University of Vienna

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials6

Recruiting2

Completed3

Countries1

Therapeutic footprint

adhddepressionneuro_oncologyocd

Indexed studies

NCT01477203Multimodal Assessment of Neurobiological Markers for Psychiatric Disorders
depression · AustriaPHASE4

NCT05655754Comparison of Esketamine/Propofol and Methohexital Anesthesia for ECT
depression · AustriaPHASE4

NCT02152748Disease Progression and Treatment-induced Alterations in Glioblastoma
neuro_oncology · AustriaUNKNOWN

NCT01108354The Serotonin Transporter in Attention Deficit Hyperactivity Disorder
adhd · AustriaCOMPLETED

NCT05577598Glucose Consumption During Deep Brain Stimulation With Functional [18F]FDG-Brain-PET in Obsessive-Compulsive Disorder
ocd · AustriaNA

NCT01057329Therapeutic Drug Monitoring in Child and Adolescent Psychiatry
adhd · AustriaCOMPLETED

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →